A breakthrough new vaccine is being developed for whooping cough after an outbreak killed 11 babies in the UK. The vaccine, ...
Researchers at University of Tsukuba have demonstrated that during Japan's COVID-19 booster vaccination campaign, online information influenced vaccination intentions in ways similar to the initial ...
A new vaccine being developed for whooping cough could offer better protection and stop the virus spreading, scientists have ...
Whooping cough, a bacterial infection that can be especially dangerous for babies and young children, is on the rise. As of ...
Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.
MedPage Today on MSN
Some Older Adults Could Use an RSV Booster Shot, Study Suggests
Real-world effectiveness with the recommended single dose of respiratory syncytial virus (RSV) vaccination dipped in older ...
Despite existing NHS vaccines for babies, children, and pregnant women, a government-funded trial showed the BPZE1 nasal ...
But now, a new Government-funded clinical trial has found a new nasal spray vaccine can stop whooping cough bacteria from ...
Most US teens have received a dose of the meningococcal vaccine, yet uptake of the first dose and completion of the booster ...
Scientists create a vaccine that shields against Crimean-Congo hemorrhagic fever within days and protects for over a year.
A joint procurement contract between the EU and Danish manufacturer Bavarian Nordic strengthens vaccine preparedness against ...
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results